Dr. Lindsay Eltis, a professor in the Department of Microbiology and Immunology at The University…
pthomsonMay 26, 2022
The accumulation of protein inclusions is linked to many neurodegenerative diseases that typically develop in…
pthomsonMay 25, 2022
A recent publication from BC Cancer’s Personalized OncoGenomics (POG) program describes the genomic profiles of…
pthomsonMay 25, 2022
Meet Ali — Contributing to scientific discovery through his background in microbiology. He works in…
pthomsonMay 25, 2022
On May 19, members of the UBC Medicine community were recognized by Clinical Trials BC…
pthomsonMay 25, 2022
Many wild salmon populations in B.C. have experienced substantial declines over the last three decades.…
pthomsonMay 24, 2022
The Canadian National Proteomics Network (CNPN) has named Dr. Leonard Foster (UBC Biochemistry and Molecular…
pthomsonMay 24, 2022
AbCellera and Harbour Antibodies, a Harbour BioMed subsidiary, enter into an agreement to combine AbCellera’s…
sciencecityJune 8, 2018
Microbiome Insights, Inc. has announced the opening of its new laboratory on the campus of…
sciencecityJune 7, 2018
’m a professor of medicine in the division of hematology-oncology, and the director of the…
sciencecityJune 5, 2018
Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, announced…
sciencecityJune 4, 2018
Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, announced…
mjoyJune 4, 2018
Glaucoma is an eye disease that is often associated with elevated intraocular pressure leading to…
sciencecityJune 1, 2018
Historically, heparins were the mainstay of anticoagulant therapy. They were the primary agents used to…
sciencecityMay 31, 2018
